119 related articles for article (PubMed ID: 1318157)
1. The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer.
Cole SP
Can J Physiol Pharmacol; 1992 Mar; 70(3):313-29. PubMed ID: 1318157
[TBL] [Abstract][Full Text] [Related]
2. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Mirski SE; Gerlach JH; Cole SP
Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.
Cole SP; Pinkoski MJ; Bhardwaj G; Deeley RG
Br J Cancer; 1992 Apr; 65(4):498-502. PubMed ID: 1314068
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
6. Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line.
Evans CD; Mirski SE; Danks MK; Cole SP
Cancer Chemother Pharmacol; 1994; 34(3):242-8. PubMed ID: 8004758
[TBL] [Abstract][Full Text] [Related]
7. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
Cole SP; Downes HF; Mirski SE; Clements DJ
Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
[TBL] [Abstract][Full Text] [Related]
8. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line.
Feldhoff PW; Mirski SE; Cole SP; Sullivan DM
Cancer Res; 1994 Feb; 54(3):756-62. PubMed ID: 8306338
[TBL] [Abstract][Full Text] [Related]
9. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line.
Mirski SE; Cole SP
Cancer Res; 1989 Oct; 49(20):5719-24. PubMed ID: 2571409
[TBL] [Abstract][Full Text] [Related]
10. Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line.
Cole SP
Cancer Chemother Pharmacol; 1990; 26(4):250-6. PubMed ID: 1973363
[TBL] [Abstract][Full Text] [Related]
11. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
[TBL] [Abstract][Full Text] [Related]
12. [Influence of interference of WIG-1 on the multi-drug resistance in small cell lung cancer].
Luo S; Bai Y; Lan H
Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):733-8. PubMed ID: 25567302
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines.
Mirski SE; Cole SP
Br J Cancer; 1991 Jul; 64(1):15-22. PubMed ID: 1677258
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
Jensen PB; Christensen IJ; Sehested M; Hansen HH; Vindeløv L
Br J Cancer; 1993 Feb; 67(2):311-20. PubMed ID: 8094293
[TBL] [Abstract][Full Text] [Related]
16. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP
Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
18. A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin.
Supino R; Binaschi M; Capranico G; Gambetta RA; Prosperi E; Sala E; Zunino F
Int J Cancer; 1993 May; 54(2):309-14. PubMed ID: 8098017
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell.
Almquist KC; Loe DW; Hipfner DR; Mackie JE; Cole SP; Deeley RG
Cancer Res; 1995 Jan; 55(1):102-10. PubMed ID: 7805019
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood mononuclear cells express antigens associated with multidrug resistance in a small cell lung cancer cell line.
Krebes KA; Mirski SE; Pross HF; Cole SP
Anticancer Res; 1993; 13(2):317-21. PubMed ID: 7685987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
